Stay updated on Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.

Latest updates to the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a dedicated Locations section that lists Wisconsin as a site, aligning with core page content and helps users find where the study is conducted. The prior Wisconsin Locations label was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check56 days agoChange DetectedAdded notes clarifying that publications are provided voluntarily by study submitters and auto-filled from PubMed, and updated the revision to v3.3.2. The previous wording about publications and PubMed data provenance was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedDeleted the government funding/operating status notice banner. The study details and other page content remain unchanged.SummaryDifference0.3%

- Check77 days agoChange DetectedNo additions or deletions were detected on the page; the study details and sections appear unchanged.SummaryDifference0.3%

- Check106 days agoChange DetectedAdditions introduce a government operating-status notice and a version update to v3.2.0; deletions remove the previous v3.1.0 tag. The main impact is informing users about current status and a version change, with no changes to core offers or pricing.SummaryDifference2%

Stay in the know with updates to Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.